Skip to main content

ALSUntangled #68: ozone therapy.

Publication ,  Journal Article
Sun, Y; Barkhaus, P; Barnes, B; Beauchamp, M; Benatar, M; Bertorini, T; Bromberg, M; Carter, GT; Crayle, J; Cudkowicz, M; Dimachkie, M ...
Published in: Amyotroph Lateral Scler Frontotemporal Degener
August 2023

ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). Here we review ozone therapy. Ozone therapy has possible mechanisms for slowing ALS progression based on its antioxidant, anti-inflammatory, and mitochondrial effects. A non-peer-reviewed report suggests that ozone treatment may slow progression in a mTDP-43 mouse model of ALS. One verified "ALS reversal" occurred on a cocktail of alternative treatments including ozone. There are no ALS trials using ozone to treat PALS. There can be potentially serious side effects associated with ozone therapy, depending on the dose. Based on the above information, we support an investigation of ozone therapy in ALS cell or animal models but cannot yet recommend it as a treatment in PALS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

August 2023

Volume

24

Issue

5-6

Start / End Page

548 / 552

Location

England

Related Subject Headings

  • Mitochondria
  • Mice
  • Humans
  • Disease Models, Animal
  • Animals
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sun, Y., Barkhaus, P., Barnes, B., Beauchamp, M., Benatar, M., Bertorini, T., … Bedlack, R. (2023). ALSUntangled #68: ozone therapy. Amyotroph Lateral Scler Frontotemporal Degener, 24(5–6), 548–552. https://doi.org/10.1080/21678421.2022.2145904
Sun, Yuyao, Paul Barkhaus, Benjamin Barnes, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Mark Bromberg, et al. “ALSUntangled #68: ozone therapy.Amyotroph Lateral Scler Frontotemporal Degener 24, no. 5–6 (August 2023): 548–52. https://doi.org/10.1080/21678421.2022.2145904.
Sun Y, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, et al. ALSUntangled #68: ozone therapy. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5–6):548–52.
Sun, Yuyao, et al. “ALSUntangled #68: ozone therapy.Amyotroph Lateral Scler Frontotemporal Degener, vol. 24, no. 5–6, Aug. 2023, pp. 548–52. Pubmed, doi:10.1080/21678421.2022.2145904.
Sun Y, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, Bromberg M, Carter GT, Crayle J, Cudkowicz M, Dimachkie M, Feldman EL, Fullam T, Heiman-Patterson T, Jhooty S, Lund I, Mcdermott C, Pattee G, Pierce K, Ratner D, Wicks P, Bedlack R. ALSUntangled #68: ozone therapy. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5–6):548–552.

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

August 2023

Volume

24

Issue

5-6

Start / End Page

548 / 552

Location

England

Related Subject Headings

  • Mitochondria
  • Mice
  • Humans
  • Disease Models, Animal
  • Animals
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences